ReBEC: online platform disseminates research and clinical trials conducted in Brazil
All studies that evaluate the clinical, pharmacological or side effects of drugs in humans are called clinical trials. In order to conduct these studies in Brazil, participating institutions must resort to their own Ethics Committees or partner institutions, which analyze research according to the National Ethics and Research Council (Conep) and the National Health Surveillance Agency (Anvisa).
To meet national and regional information needs and provide transparency to studies, the Brazilian Registry of Clinical Trials (ReBEC) - an online platform for experimental and observational studies - disseminates various research on a specific disease or drug that is underway in Brazil, through data that does not always find space in scientific journals. Managed by Fiocruz and publicly owned, the service has free access, free of charge for anyone who wants to register or consult approved records.